Insights

DISCOVER

COMPANY

Survey

SURVEY

Consulting

COUNSULTING

Create New Account

Book discovery call

UAE Blood Gas, Immunoassay Analyzer and Transcutaneous Monitoring Market Outlook to 2025

Rising demand for quality healthcare and growing privatization in the healthcare sector will drive the medical diagnostic equipment market in UAE

Region:Middle East

Author(s):Aishwarya Kochhar

Product Code:KR1108

Download Sample Report

Published On

December 2021

Total pages

Download Sample Report

About the Report

The report titled “UAE Blood Gas, Immunoassay Analyzer and Transcutaneous Monitoring Market Outlook to 2025- Rising demand for quality healthcare and growing privatization in the healthcare sector will drive the medical diagnostic equipment market in UAE” provides a comprehensive analysis of the Diagnostic Equipments used in ICU and NICUs. The report also covers overview and genesis of the industry, product wise market size in terms of installed base and revenue; market segmentation by type of product, type of device, type of workload, type of sales model, type of entity, type of region and by type of end users; snapshot on Blood Gas Analyzer, POC Immunoassay Analyzer and Transcutaneous Monitor Market, trends and developments, issues and challenges and comparative landscape including competition scenario, market shares of major brands based on Installed base, opportunities and bottlenecks in UAE. The report concludes with future market projections of each product segmentation and Analyst recommendations for Marketing & Promotional Strategies including Business Framework.

UAE Diagnostic Device Market (BGA, POC IAA and TCM) Overview and Size: UAE Diagnostic Device market to show a steady growth rate over the review period 2020-2025 supported by increase in geriatric population in the country along with the transition of healthcare facilities from central lab devices to POC Devices. Improvement in healthcare infrastructure is also going to generate demand for such products in UAE.

Detailed Analysis on the Blood Gas Analyzer (BGA) Market: UAE BGA Market is an import driven market, mainly importing from European countries and requiring mandatory CE certificate. Nearly 90% of the hospitals across UAE have been equipped with blood gas analyzers with around 3 machines deployed at each facility.

It is a concentrated market, largely occupied by Radiometer devices. Most Devices in the market are POC Devices with Abbott istat being the selling device in the market. Healthcare facilities in UAE highly prefer the Radiometer ABL 90 and Abbott iStat Model in the point of care setting due to its high quality results and portability respectively.

Many Chinese, Japanese and Korean companies are eyeing on the UAE BGA Market as these

devices are currently in the pipeline of getting registered by DOH. Advancing technologies in the BGA market such as Portable equipments and AI for digital systems would help rise in the sales volume.

Blood Gas Analyzer (BGA) Market Segmentations:

By Product: POC Devices have dominated the market in terms of installations in 2020 followed by POC Benchtop and Handheld Device. The trend was largely due to the growing interest of the users in portable and easy handling devices

By Demand Type: Only CE Marked and registered devices are available for Tender Based Sale in UAE. Government Entities and Large size hospitals prefer tender process and usually invite bug brand names

By Sales Model and Workload: Consumable Model contributed majority percentage share in terms of installations in 2020. BGA market has a low percentage for the outright sale model and high installation for Single Test Analyzers, which are offered by the handheld devices such as iStat by Abbott.

By Type of Healthcare Facilities: Government hospitals have a high no. of installed BGA with >80% of the market captured in UAE. Highest install base in the government hospitals, which includes accredited or affiliated hospitals from MOH, SEHA and DOH.

By Region: Abu Dhabi has the highest number of hospitals, hence corresponding to the high number of BGA Installed Units.

Detailed Analysis on the UAE POC Immunoassay Analyzer (IAA) Market

POC Immunoassay Analyzer market is relatively less mature market and growing on a steady pace in UAE. High Prevalence of myocardial diseases, infections and other non-communicable diseases along with the COVID Impact, since it slightly increased the number of testing in COVID positive patients, are driving the market growth.

It is a concentrated market with Abbott leading the market in UAE with more than 50% of total installed base till 2020 and has sustained its position in the market by introducing high quality devices which are rich in features. iStat from Abbott is a popular choice for most end users along with Cobas from Roche and Atellica VTLi analyzer from Siemens.

POC IAA Market is expected to generate revenues worth more than $5 Mn in 2025 owing to technological advancements and standardizing protocols. Devices are advancing continuously in terms of size and operating parameters and is expected to see low maintenance and high quality multi parametric device in future.

POC Immunoassay Analyzer (IAA) Market Segmentations:

By Product: POC Benchtop has dominated the market in terms of installations in 2020. However, POC Handheld IAA is becoming a popular choice. Abbott and Roche are a popular brand for Handheld and Benchtop Point of Care Immunoassay analyzers respectively in UAE

By Sales Model: IAA market has a low percentage for the outright sale model. Outright sales model is usually preferred for the handheld devices. Consumable sales model is highly followed due to the variations in the no. of tests and types of tests conducted on each machine.

By Demand and Entity Type: Majority of the POC Immunoassay are sold via Tender based process largely addressing hospitals as the end users. Popular hospitals in UAE for IAA market are Cleveland hospitals, Al Zahra Hospital, Canadian Specialist Hospital, Saudi German Hospital, Zulekha Hospital and more.

By Region: Highest no. of POC IAA units are installed in Abu Dhabi region followed by Dubai in UAE.

Detailed Analysis on the UAE Transcutaneous Monitors (TCM) Market: TCM device has a low penetration rate in UAE. It is predominantly sold as a technology by its integration in another device generating more B2B sales over B2C sales. Currently TCM devices have started operating on non-invasive technologies to avoid the painful invasive techniques on infants.

There are limited no. of players in the market selling their device in UAE Transcutaneous Monitors (TCM) Market .TCM by Sentec has become a popular choice due to its high brand awareness and non-invasive technology. Most of the TCM Device brands have partnered with an exclusive distributor for their sales and promotion in UAE.

TCM Market is expected to witness growth of 5.8% CAGR (2020-2025F) due to increased number of trained staff and NICUs and PICUs. End Users are targeting to provide holistic cost effective and family oriented care package for effective growth.

UAE Transcutaneous Monitors (TCM) Market Segmentations:

By Type of Demand: Tender Demand have high share in terms of installations than Non Tender Demand in UAE Transcutaneous Monitors (TCM) Market.

By Type Of Healthcare Facilities: Hospitals dominate the market followed by Independent labs such sleep labs as well as home healthcare.

By Type of Region: On the basis of installed units UAE is divided into three regions Dubai, Abu Dhabi and Other Emirates (Sharjah, Ajman, Umm Al-Quwain, and Fujairah) out of which Abu Dhabi has the highest number of installations.

Key Topics Covered in the Report

UAE Diagnostic Device (BGA, POC IAA and TCM) Introduction
Market Ecosystem
Value chain Analysis
Detailed Analysis on Blood Gas Analyzer Market in UAE (Market Size, 2020; Market Segmentation; Market Shares; Product Comparison; Competition; Future Market Size, 2025; Future Trends and Technologies)
Detailed Analysis on Immunoassay Analyzer Market in UAE (Market Size, 2020; Market Segmentation; Market Shares; Product Comparison; Competition; Future Market Size, 2025; Future Trends and Technologies)
Detailed Analysis on Transcutaneous Monitors Market in UAE (Market Size, 2020; Market Segmentation; Market Shares; Product Comparison; Competition; Future Market Size, 2025; Future Trends and Technologies)
Major Challenges in UAE Diagnostic Device (BGA, POC IAA and TCM) Market
Business Opportunity (Customer Analysis, Major upcoming Healthcare Projects in UAE)
Recommendations (Sales and Marketing Strategies, Positioning Strategies, Business Framework)

Products

Key Target Audience

Healthcare Industry
Medical Device Manufacturing Companies
Medical Device Distributors
Hospitals
Multi speciality and Super Specaility Clinics
Diagnostic Centers
Sleep Labs Centers
Home Healthcare Centres

Time Period Captured in the Report:

Base Year: 2020
Forecast Period: 2021F–2025F

Companies

Key Segments Covered

Blood Gas Analyzer

By Installed Base
By Revenue
By Type of Product
By Type of Demand
By type of Entity
By Type of Workload
By Type of Device
By type of Sales Mode
By End User
By Region

POC Immunoassay Analyzer

By Installed Base
By Revenue
By Type of Product
By Type of Demand
By type of Entity
By type of Sales Mode
By End User
By Region

Transcutaneous Monitors

By Installed Base
By Type of Product
By End User
By Hospital Sector
By Region

Companies Covered:

Equipments Manufacturers

Roche Diagnostics
Abbott
Siemens
Nova Biomedical
Radiometer
Techno Medica
Wondfo
Osang Healthcare
i-Sens
Opti Medical
Werfen
Sysmex
LSI Medicine and Others

1. Executive Summary

1.1. Executive Summary (Installed base, revenue, CAGR, product segmentations, growth drivers)

1.2. Competition Scenario (Top players in each product segmentation)

1.3. Market Scenario (Market type and consolidation ratio for each product type)

2. Overview of the Blood Gas Analyzer, POC Immunoassay Analyzer and Transcutaneous Monitors Market

2.1. Country overview of UAE (country demographics, major industries, GDP, Trade scenario)

2.2. Demographics of UAE (Population Stats in UAE)

2.3. Healthcare Infrastructure in UAE (No. of Hospitals by type, No. of Beds by type of
Hospitals, No. of Public Clinics)

2.4. Disease prevalence; Cardiovascular Disease, Immunological disease and Neonatal Diseases

3. UAE Blood Gas Analyzer, POC Immunoassay Analyzer and Transcutaneous Monitor Market Analysis

3.1 Business cycle of the three devices Blood Gas Analyzer, Immunoassay Analyzer and Transcutaneous Monitor Market Analysis

3.2 Timeline of major distributors in the Diagnostic device market in UAE

3.3 Industry Ecosystem (Supply side)

3.4 Value Chain Analysis (Lead time, Margins, Procurement and distribution)

3.5 Challenges and Bottlenecks prevailing in the industry

3.6 Competitive Landscape for all the three device

4. UAE Blood Gas Analyzer Market

4.1. Executive Summary (Current Scenario, Key Highlights, Growth Drivers)

4.2. Market Size for Blood Gas Analyzer in UAE (Installed base and sales revenue)

4.3. Market Segmentation for the Blood Gas Analyzer Products (By type of Product, Type of
Device, type of sales model, type of workload, type of entity, type of demand By type of end
user, type of region on the basis of installed units)

4.4. Brand Shares (on the basis of Installed units: Abbott, Radiometer, Roche, Siemens
Healthineers and Others)

4.5. Qualitative and Quantitative Cross Comparison between Major Brands (on the basis of
distributor name, distribution type, best-selling device, installed units, price of device,
cost per test)

4.6. Cross Comparison between Major Brands (Strengths and Weakness)

4.6. Product Comparison (Product Series, Features, Average Pricing)

4.7. Future Projections (Future Market Size and Product Segmentation)

4.8. Emerging Trends and Future Technologies

5. UAE POC Immunoassay Analyzer Market

5.1. Executive Summary (Current Scenario, Key Highlights, Growth Drivers)

5.2. Market Size for Immunoassay Analyzer in UAE (Installed base and sales revenue)

5.3. Market Segmentation for the Immunoassay Analyzer Products (By type of Product, type of
sales model, type of entity, type of demand By type of end user, type of region on the basis of
installed units)

5.4. Brand Shares (on the basis of Installed units: Abbott, Radiometer, Roche, Siemens
Healthineers and Others)

5.5. Qualitative and Quantitative Cross Comparison between Major Brands (on the basis of
distributor name, distribution type, best-selling device, installed units, price of device,
cost per test)

5.6. Cross Comparison between Major Brands (Strengths and Weakness)

5.7. Product Comparison (Product Series, Features, Average Pricing)

5.8. Future Projections (Future Market Size and Product Segmentation)

5.9. Emerging Trends and Future Technologies

6. UAE Transcutaneous Monitor Market

6.1. Executive Summary (Current Scenario, Key Highlights, Growth Drivers)

6.2. Market Size for Transcutaneous Monitor Marketin UAE (by Installed base and sales revenue)

6.3. Market Segmentation for the Transcutaneous Monitor (by type of entity, type of demand By
type of end user, type of region on the basis of installed units)

6.4. Brand Shares (on the basis of Installed units: Sentec, Radiometer, Perimed and Others)

6.5. Cross Comparison between Major Brands (on the basis of distributor name, distribution
type, best-selling device, installed units, price of device)

6.6. Cross Comparison between Major Brands (Strengths and Weakness)

6.7. Product Comparison (Product Series, Features, Average Pricing)

6.8. Future Projections (Future Market Size and Product Segmentation)

6.9. Emerging Trends and Future Technologies

7. Industry Qualitative factors

7.1. Government Role and Regulation for Blood Gas Analyzer, Immunoassay Analyzer and
Transcutaneous Monitors

7.2. End User perception (by the end users, type of device, brand preference)

8. Recommendations

8.1. Understanding the Buying Decision Process

8.2. Customer Journey

8.3. Sales and Promotion Strategy

8.4 Business Framewrok

9. The way forward

9.1. The next step

10. Appendix

11. Research Methodology

12. Disclaimer

13. contact us

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022